Activated CAFs further promote cancer progression by secreting angiogenic cytokines, including VEGF, MMP2, MMP9, b-FGF, and TGF-β, and enhance EMT progression in hepatoma cells (Zhou et al., 2018). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.